Tango Therapeutics to go public via merger with Boxer Capital-backed SPAC

Tango Therapeutics, a biotech company, has agreed to go public via a merger with BCTG Acquisition Corp, a blank check company backed by Boxer Capital.

14 April 2021•5 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles